147 results on '"Shafman, Timothy"'
Search Results
2. The American Society for Radiation Oncology's 2015 Core Physics Curriculum for Radiation Oncology Residents
3. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma
4. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis
5. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings
6. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
7. Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC Development and External Validation of a Multi-Institutional Model: development and external validation of a multi-institutional model
8. Radiation-Induced Lung and Heart Toxicity
9. Radiation-Induced Lung and Heart Toxicity
10. Activation of the pp90 rsk and Mitogen-Activated Serine/Threonine Protein Kinases by Ionizing Radiation
11. A Phase I Study of Dose-Dense Topotecan Given Upfront to Standard Therapy in Patients with Small Cell Lung Cancer
12. Clear cell pleomorphic xanthoastrocytoma: case report
13. Brain Metastases from Malignant Melanoma
14. Interaction between ATM protein and c-Abl in response to DNA damage
15. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
16. Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
17. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents
18. Activation of the pp90rsk and mitogen-activated serine/threonine protein kinases by ionizing radiation
19. Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy
20. Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas
21. Using Plasma Transforming Growth Factor Beta-1 During Radiotherapy to Select Patients for Dose Escalation
22. Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones
23. Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas
24. Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer
25. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
26. Multi-center assessment of stereotactic body radiotherapy in oligometastatic prostate cancer.
27. Changes in prostate cancer presentation for radiation oncology care after USPSTF recommendations, 2007-2013.
28. Radiation-Induced Lung and Heart Toxicity
29. Current Status of Immunotherapy and Gene Therapy for High-Grade Gliomas
30. The utility of non-axial treatment beam orientations for lower lobe lung cancers
31. Dose-Dependent Effects of Radiation Therapy on Cerebral Blood Flow, Metabolism, and Neurocognitive Dysfunction
32. Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury
33. Challenges in defining radiation pneumonitis in patients with lung cancer
34. “Anatomically-correct” dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics
35. Dosimetric and clinical predictors for radiation-induced esophageal injury
36. Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer?
37. Radiosurgery, Volume 4
38. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer
39. Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer
40. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury
41. THE time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up
42. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer
43. Relating radiation-induced regional lung injury to changes in pulmonary function tests
44. Prevalence of germline truncating mutations inATM in women with a second breast cancer after radiation therapy for a contralateral tumor
45. Novel radiation technologies for malignant gliomas
46. Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease
47. Prevalence of ataxia-telangiectasia heterozygosity in patients developing contralateral breast cancer following treatment with conservative surgery and radiation therapy
48. Ionizing Radiation Stimulates a Grb2-mediated Association of the Stress-activated Protein Kinase with Phosphatidylinositol 3-Kinase
49. Prognostic factors in stage I and II diffuse large cell lymphoma patients treated with multiagent chemotherapy alone or combined with radiation therapy
50. Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.